Top

LATEST PUBLICATIONS



Biogen brings in a successor to Spinraza

January 4, 2022

First approved in late 2016, Spinraza has become one of the most important medicines in Biogen’s arsenal, accounting for about a fifth of the company’s total product revenue. Recently, though, the Spinraza franchise hasn’t fared as well due to competitive […]


Industry Warming to 24/7 Production

December 28, 2021

Anton Middelberg, PhD, deputy vice-chancellor and vice-president of research at the University of Adelaide in Australia, believes industry reluctance to go continuous reflects the traditional focus on batch-mode production and, in some areas, the technical challenges. “The complexity in continuous […]


2022 forecast: Pharma has the tools. Will clinical trials be less white in 2022?

December 22, 2021

The data are clear: White patients are taking up the majority of clinical trials. About 130 million Americans across various races are “being somewhat ignored, [or] deprioritized, in clinical trials” that support regulatory approval, said Yele Aluko, M.D., chief medical […]


Industry, Vaccines

mRNA COVID-19 vaccines safe for pregnant women, finds EMA review

January 19, 2022

Via: European Pharmaceutical Review

According to the European Medicines Agency (EMA)’s COVID-19 task force (ETF), a growing body of evidence suggests that messenger RNA (mRNA) COVID-19 vaccines do not cause pregnancy complications for expectant mothers and their babies. The ETF undertook a detailed review […]


Industry, Vaccines

WHO Says Worst of Pandemic Could Ease This Year if Vaccine Inequities Erased

January 19, 2022

Via: Drugs.com

If COVID-19 vaccines and medicines are shared equally worldwide, the pandemic could ease this year, a top World Health Organization official said Tuesday. However, if wealthier countries don’t share their resources with poorer countries, there will continue to be high […]


Manufacturing, Research and Development

Ori Biotech reaps $100M in series B round to help launch innovative cell manufacturing tech

January 18, 2022

Via: FiercePharma

Ori Biotech, which is on the cusp of launching an innovative process for manufacturing cell and gene therapies (CGTs), tallied more than $100 million in its latest funding round. The company will use the money to add key personnel in […]


Manufacturing, Research and Development

Stanford spinout forms drug delivery joint venture with Chinese biotech

January 18, 2022

Via: FiercePharma

Stanford University spinout N1 Life has formed a joint venture to further its drug delivery ambitions. The startup is teaming up with Accuredit Therapeutics to create a joint venture, Napoltec, focused on novel drug delivery systems and the progression of […]


Biotech, Industry

How CRO venture capital relationships can help biotech fundraising

January 18, 2022

Via: Biopharma Dive

Developing drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]


Manufacturing, Research and Development

Samsung Biologics to Construct New Manufacturing Facility for Next-Gen Vaccines and CGT

January 18, 2022

Via: Biopharm International

Samsung Biologics announced on Jan. 12, 2022 that it plans to start building a new facility (designated Plant 5) at Songdo in Incheon, South Korea, this year. The facility will offer manufacturing for multi-modal products, including cell and gene therapies […]